Patent: 9,517,253
✉ Email this page to a colleague
Summary for Patent: 9,517,253
Title: | Compositions for treating multiple sclerosis |
Abstract: | Compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis. |
Inventor(s): | Foussat; Arnaud (Biot, FR) |
Assignee: | TXCELL (Valbonne, FR) |
Application Number: | 12/738,706 |
Patent Claims: | see list of patent claims |
Details for Patent 9,517,253
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2027-10-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |